Immunomodulatory properties of the fresh Curcuma longa rhizome extract CPSP-01 on HT-29 cell-line
Planta Medica · 01.03.2026 · 92 (03) · 241
DOI: 10.1055/s-0045-1814973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von A Abot und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Turmeric ( Curcuma longa L.), widely used as a condiment and flavouring agent, has also long been employed in traditional medicine for its anti-inflammatory and analgesic properties. Most industrial extracts are obtained from heat-treated rhizomes, standardized to high levels of curcuminoids (80-95%), and largely documented for their biological activities. However, the rhizome of C. longa contains a broader chemical diversity, and the biological activity of extracts with lower curcuminoid content but richer phytochemical profiles remain underexplored. In our study, the properties of the fresh C. longa rhizome extract CPSP-01 (25 and 50 μg/mL, 50% hydroethanolic extract, 8% curcuminoids, HPTLC-characterized for the presence of terpenes and amino acids) were evaluated on HT-29 cell-line challenged or not with LPS using butyrate as reference. Key markers of immunomodulation, gut barrier function and antioxidative defences were investigated. Under basal conditions, neither butyrate nor CPSP-01 affected IL-8 secretion or Tnf-α expression. Butyrate upregulated IL-10 without altering Cox-2 expressions. Conversely, CPSP-01 decreased Cox-2 without affecting Il-10 expressions. Under challenge with LPS, butyrate reduced the pro-inflammatory biomarkers and tended to increase anti-inflammatory biomarkers. CPSP-01 tended to reduce IL-8 secretion, decreased Tnf-α expression at the highest dose, lowered Cox-2 and tended to increase IL-10 expression. Notably, the effect of CPSP-01 on Cox-2 expression was significantly more pronounced compared to butyrate. No significant changes were observed in Zo-1, Ocln, Muc-2, or Nrf2 expression, suggesting no effect on the barrier function and antioxidative defences. These findings provide valuable insights into the potential therapeutic applications of CPSP-01 in the modulation of inflammation. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Abot, A., Berthomier, L., Cotte, C., Bardot, V., Blondeau, C., Holowacz, S., & Leblanc, A. (2026). Immunomodulatory properties of the fresh Curcuma longa rhizome extract CPSP-01 on HT-29 cell-line. Planta Medica, 92(03), 241. https://doi.org/10.1055/s-0045-1814973
Vancouver
Abot A, Berthomier L, Cotte C, Bardot V, Blondeau C, Holowacz S, et al. Immunomodulatory properties of the fresh Curcuma longa rhizome extract CPSP-01 on HT-29 cell-line. Planta Medica. 2026;92(03):241. doi:10.1055/s-0045-1814973
BibTeX
@article{Abot2026,
author = {Abot, A and Berthomier, L and Cotte, C and Bardot, V and Blondeau, C and Holowacz, S and Leblanc, A},
title = {Immunomodulatory properties of the fresh Curcuma longa rhizome extract CPSP-01 on HT-29 cell-line},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {241},
doi = {10.1055/s-0045-1814973}
}
EUVIMED